<DOC>
	<DOC>NCT01970306</DOC>
	<brief_summary>The purpose of this study is to see if implanting MatriStem will lower the risk of one of the more common complications after stomach or esophagus surgery.</brief_summary>
	<brief_title>Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Patient 18 years of age or older Pathologically confirmed Gastric, Gastroesophageal Junction (GEJ) or Esophageal, adenocarcinoma at MSKCC (biopsy may be performed at other institutions but slides must be confirmed at MSKCC, as is routine care at our institution) Patient undergoing any resection requiring an anastomosis to the esophagus for curative intent. Including but not limited to esophagectomy or total gastrectomy. Subject is willing to provide written informed consent Subject is willing and able to comply with the followup regimen Pregnant or lactating women Intraoperative evidence of metastatic or locallyunresectable disease Patients with known sensitivity or allergy to porcine materials. Patients undergoing any resection requiring an anastomosis to the esophagus for palliative intent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Esophageal Reinforcement</keyword>
	<keyword>ACell MatriStem</keyword>
	<keyword>13-178</keyword>
</DOC>